ADAMIS PHARMACEUTICALS CORP (ADMP) Stock Price, Quote, News and Overview
NASDAQ:ADMP - Nasdaq - US00547W3079 - Common Stock - Currency: USD
ADMP Quote, Performance and Key Statistics
0.7751
+0.01 (+0.86%)
The current stock price of ADMP is 0.7751 USD. In the past month the price decreased by -42.59%. In the past year, price decreased by -96.65%.
ADMP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About ADMP
Company Profile
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The firm's Tempol, is an investigational drug.
Company Info
ADAMIS PHARMACEUTICALS CORP
Suite 310, 11455 El Camino Real
San Diego CALIFORNIA 92130 US
CEO: Dennis J. Carlo
Employees: 11
Company Website: https://www.adamispharmaceuticals.com/
Phone: 18589972400.0
ADAMIS PHARMACEUTICALS CORP / ADMP FAQ
What is the stock price of ADAMIS PHARMACEUTICALS CORP today?
The current stock price of ADMP is 0.7751 USD. The price increased by 0.86% in the last trading session.
What is the ticker symbol for ADAMIS PHARMACEUTICALS CORP stock?
The exchange symbol of ADAMIS PHARMACEUTICALS CORP is ADMP and it is listed on the Nasdaq exchange.
On which exchange is ADMP stock listed?
ADMP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ADAMIS PHARMACEUTICALS CORP stock?
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751. Check the ADAMIS PHARMACEUTICALS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ADAMIS PHARMACEUTICALS CORP worth?
ADAMIS PHARMACEUTICALS CORP (ADMP) has a market capitalization of 2.16M USD. This makes ADMP a Nano Cap stock.
How many employees does ADAMIS PHARMACEUTICALS CORP have?
ADAMIS PHARMACEUTICALS CORP (ADMP) currently has 11 employees.
What are the support and resistance levels for ADAMIS PHARMACEUTICALS CORP (ADMP) stock?
ADAMIS PHARMACEUTICALS CORP (ADMP) has a resistance level at 0.87. Check the full technical report for a detailed analysis of ADMP support and resistance levels.
Should I buy ADAMIS PHARMACEUTICALS CORP (ADMP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ADMP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ADMP, evaluating the profitability, health, valuation and growth aspects
- ADAMIS PHARMACEUTICALS CORP (ADMP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ADAMIS PHARMACEUTICALS CORP (ADMP) Sales and EPS estimates to see what analysts future expectations are.
- ADAMIS PHARMACEUTICALS CORP (ADMP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ADAMIS PHARMACEUTICALS CORP (ADMP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ADAMIS PHARMACEUTICALS CORP (ADMP) Stock Chart to make your own analysis
- ADAMIS PHARMACEUTICALS CORP (ADMP) Latest news and press-releases to stay up to date.
Does ADAMIS PHARMACEUTICALS CORP (ADMP) stock pay dividends?
ADMP does not pay a dividend.
When does ADAMIS PHARMACEUTICALS CORP (ADMP) report earnings?
ADAMIS PHARMACEUTICALS CORP (ADMP) will report earnings on 2023-11-13, after the market close.
What is the Price/Earnings (PE) ratio of ADAMIS PHARMACEUTICALS CORP (ADMP)?
ADAMIS PHARMACEUTICALS CORP (ADMP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.03).
ADMP Technical Analysis
ADMP Financial Highlights
Over the last trailing twelve months ADMP reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 40.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ADMP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to ADMP. The Buy consensus is the average rating of analysts ratings from 6 analysts.